In the first study, it was showed that SOX10 is required for proliferation of melanoma tumor cell and that SOX10 haploinsufficiency reduces melanoma initiation in the metabotropic glutamate receptor 1 [Grm1(Tg)] transgenic mouse model. Here, SOX10 is linked to neoplasm.